Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Jan-Mar;15(1):127-30.
doi: 10.4293/108680811X13022985131732.

The wandering Mirena: laparoscopic retrieval

Mark Erian  1 , Glenda McLaren, David Baartz
Affiliations
Case Reports

The wandering Mirena: laparoscopic retrieval

Mark Erian et al. JSLS. 2011 Jan-Mar.

Abstract

Levonorgestrel-containing intrauterine contraceptive devices, marketed as Mirena (Bayer HealthCare Pharmaceuticals, Inc. Australia) are widely used in contemporary gynecology, primarily as an effective method for contraception and for control of menstrual disorders like menorrhagia and dysmenorrhea. In this article, the authors report 2 cases of Mirena migration following intrauterine insertion by general practitioners (family physicians). In the first case, the contraceptive device had moved to the patient's right iliac fossa just anterior to the cecum and, in the second, within the peritoneal cavity close to the left leaf of the diaphragm. Both patients underwent uneventful laparoscopic retrieval of the devices.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Migrated Mirena® lying within abdominal cavity on top of the cecum, surrounded by omental adhesions.
Figure 2.
Figure 2.
Laparoscopic retrieval of the migrated Mirena® device, following an adhesiolysis procedure.
Figure 3.
Figure 3.
Migrated Mirena® is close to the left leaf of the patient's diaphragm.
Figure 4.
Figure 4.
Laparoscopic retrieval of the migrated Mirena® device.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. ESHRE Capri Workshop Group Intrauterine devices and intrauterine systems. Hum Reprod Update. 2008. May-Jun;14(3):197–208 - PubMed
    1. Wildemeersch D, Jansssens D, Andrade A. The Femilis LNG-IUS: Contraceptive performance- an interim analysis. Eur J Contracept Reprod Health Care. 2009. April;14(2):103–110 - PubMed
    1. Chen EC, Danis PG, Tweed E. Clinical inquiries. Menstrual disturbances in perimenopausal women: What's best? J Fam Pract. 2009. June;58(6):E3. - PubMed
    1. Bahamondes L, Petta CA, Fernandes A, Monteiro L. Use of Levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea. Contraception. 2007. June;75(6 suppl):S123–S129 - PubMed
    1. Cameron S. Contraception and gynaecological care. Best Pract Res Clin Obstet Gynaecol. 2009. April;23(2):211–220 - PubMed

Publication types

Substances

LinkOut - more resources